Aug 17, 2015 9:03 am EDT Abeona Therapeutics Announces Recent Highlights and Second Quarter 2015 Conference Call
Aug 3, 2015 9:03 am EDT Abeona Therapeutics Announces Closing of Upsized $15.5 Million Equity Financing With Institutional Investors and Management
Jul 28, 2015 9:03 am EDT Abeona Therapeutics Announces $8.5 Million Equity Financing With Current Institutional Investors and Directors
Jul 7, 2015 9:07 am EDT Abeona Therapeutics Provides Update on SDF(TM) (Salt Diafiltration) Plasma Fractionation Products
Jul 1, 2015 9:06 am EDT Abeona Therapeutics Raises Additional $4.6 Million Through Warrant Exercises in Q2 15
Jun 22, 2015 7:03 am EDT Abeona Therapeutics Set to Join Russell Global, Russell 3000(R) and Russell MicroCap(R) Indexes
Dec 1, 2014 8:10 am EST Abeona Therapeutics Raises Foundation-led $3.6M to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases
May 12, 2014 9:00 am EDT Abeona Therapeutics Receives U.S. Orphan Drug Designations for treatment of Sanfilippo Syndromes A and B
Dec 16, 2013 9:00 am EST Abeona Therapeutics Closes $750,000 in Seed Round to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases
Oct 9, 2013 1:35 pm EDT Abeona Therapeutics and Nationwide Children's Hospital receive prestigious Global Genes "Champions of Hope" award for Patient Advocacy
